Literature DB >> 29929159

Methodological factors influencing inhalation bioaccessibility of metal(loid)s in PM2.5 using simulated lung fluid.

Farzana Kastury1, E Smith2, Ranju R Karna3, Kirk G Scheckel4, A L Juhasz2.   

Abstract

In this study, methodological factors influencing the dissolution of metal(loid)s in simulated lung fluid (SLF) was assessed in order to develop a standardised method for the assessment of inhalation bioaccessibility in PM2.5. To achieve this aim, the effects of solid to liquid (S/L) ratio (1:100 to 1:5000), agitation (magnetic agitation, occasional shaking, orbital and end-over-end rotation), composition of SLF (artificial lysosomal fluid: ALF; phagolysosomal simulant fluid: PSF) and extraction time (1-120 h) on metal(loid) bioaccessibility were investigated using PM2.5 from three Australian mining/smelting impacted soils and a certified reference material. The results highlighted that SLF composition significantly (p < 0.001) influenced metal(loid) bioaccessibility and that when a S/L ratio of 1:5000 and end-over-end rotation was used, metal(loid) solubility plateaued after approximately 24 h. Additionally, in order to assess the exposure of metal(loid)s via incidental ingestion of surface dust, PM2.5 was subjected to simulated gastro-intestinal tract (GIT) solutions and the results were compared to extraction using SLF. Although As bioaccessibility in SLF (24 h) was significantly lower than in simulated GIT solutions (p < 0.05), Pb bioaccessibility was equal to or significantly higher than that extracted using simulated GIT solutions (p < 0.05).
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ALF; Bioaccessibility; Inhalation; PM(2.5); PSF; SLF

Mesh:

Substances:

Year:  2018        PMID: 29929159      PMCID: PMC6517839          DOI: 10.1016/j.envpol.2018.05.094

Source DB:  PubMed          Journal:  Environ Pollut        ISSN: 0269-7491            Impact factor:   8.071


  7 in total

1.  Relationship between Pb relative bioavailability and bioaccessibility in phosphate amended soil: Uncertainty associated with predicting Pb immobilization efficacy using in vitro assays.

Authors:  Farzana Kastury; Silvia Placitu; John Boland; Ranju R Karna; Kirk G Scheckel; Euan Smith; Albert L Juhasz
Journal:  Environ Int       Date:  2019-07-05       Impact factor: 9.621

2.  Correlation between lead speciation and inhalation bioaccessibility using two different simulated lung fluids.

Authors:  Farzana Kastury; Ranju R Karna; Kirk G Scheckel; Albert L Juhasz
Journal:  Environ Pollut       Date:  2020-04-17       Impact factor: 8.071

3.  Human health risk assessment of PM2.5-bound heavy metal of anthropogenic sources in the Khon Kaen Province of Northeast Thailand.

Authors:  Pornpun Sakunkoo; Theerachai Thonglua; Sarawut Sangkham; Chananya Jirapornkul; Yuparat Limmongkon; Sakda Daduang; Thanee Tessiri; Jetnapis Rayubkul; Sakesun Thongtip; Naowarat Maneenin; Sittichai Pimonsree
Journal:  Heliyon       Date:  2022-06-07

4.  Potential Heavy Metals Pollution Contribution from Wash-Off of Urban Road-Dust.

Authors:  Muhammad Faisal; Zening Wu; Huiliang Wang; Xiaoying Lin; Zafar Hussain; Muhammad Imran Azam
Journal:  Toxics       Date:  2022-07-18

5.  Lead source and bioaccessibility in windowsill dusts within a Pb smelting-affected area.

Authors:  Weiqin Xing; Hao Yang; James A Ippolito; Yuqing Zhang; Kirk G Scheckel; Liping Li
Journal:  Environ Pollut       Date:  2020-06-29       Impact factor: 8.071

6.  Metal(loid) bioaccessibility of atmospheric particulate matter from mine tailings at Zimapan, Mexico.

Authors:  Jesús Eulises Corona Sánchez; Ma Del Carmen Angeles González Chávez; Rogelio Carrillo González; Kirk Scheckel; Daniel Tapia Maruri; José L García Cue
Journal:  Environ Sci Pollut Res Int       Date:  2021-01-04       Impact factor: 4.223

7.  Health Risk Assessment of Heavy Metals Accumulated on PM2.5 Fractioned Road Dust from Two Cities of Pakistan.

Authors:  Haseeb Tufail Moryani; Shuqiong Kong; Jiangkun Du; Jianguo Bao
Journal:  Int J Environ Res Public Health       Date:  2020-09-29       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.